These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.
    Author: Ghaemi SN, Sachs GS, Baldassano CF, Truman CJ.
    Journal: Can J Psychiatry; 1997 Mar; 42(2):196-9. PubMed ID: 9067070.
    Abstract:
    OBJECTIVE: To test the hypothesis that, although typical neuroleptics are commonly used in the treatment of bipolar disorder, newer atypical antipsychotic agents, like risperidone, may be more effective and better-tolerated. METHOD: The effectiveness of risperidone was evaluated in 14 outpatients with bipolar disorder, type I, who received risperidone for 6.4 +/- 2.7 weeks at 2.75 +/- 1.8 mg/day. RESULTS: Nine (64%) patients were much improved based on Clinical Global Impression (CGI) scores, and mean Global Assessment of Functioning (GAF) scores improved from 48.2 +/- 4.9 to 58.8 +/- 7.3 (t = 4.49, P = 0.0006, paired t test). Treatment was well tolerated, and no patient experienced worsening of mood symptoms while receiving risperidone. CONCLUSION: This open series suggests risperidone is beneficial in the treatment of outpatients with bipolar disorder.
    [Abstract] [Full Text] [Related] [New Search]